30 related articles for article (PubMed ID: 33279633)
1. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.
Peng RY; Mansbach RS; Braff DL; Geyer MA
Neuropsychopharmacology; 1990 Jun; 3(3):211-8. PubMed ID: 2141986
[TBL] [Abstract][Full Text] [Related]
2. The antipsychotic agent sulpiride microinjected into the ventral pallidum restores positive symptom-like habituation disturbance in MAM-E17 schizophrenia model rats.
Péczely L; Dusa D; Lénárd L; Ollmann T; Kertes E; Gálosi R; Berta B; Szabó Á; László K; Zagoracz O; Karádi Z; Kállai V
Sci Rep; 2024 May; 14(1):12305. PubMed ID: 38811614
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 Receptors in the Paraventricular Thalamus Attenuate Cocaine Locomotor Sensitization.
Clark AM; Leroy F; Martyniuk KM; Feng W; McManus E; Bailey MR; Javitch JA; Balsam PD; Kellendonk C
eNeuro; 2017; 4(5):. PubMed ID: 29071300
[TBL] [Abstract][Full Text] [Related]
4. The dose-dependent effect of the D2R agonist quinpirole microinjected into the ventral pallidum on information flow in the limbic system.
Peczely L; Grace AA
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jun; 134():111059. PubMed ID: 38901759
[TBL] [Abstract][Full Text] [Related]
5. Fingerprints of CNS drug effects: a plasma neuroendocrine reflection of D
van den Brink WJ; van den Berg DJ; Bonsel FEM; Hartman R; Wong YC; van der Graaf PH; de Lange ECM
Br J Pharmacol; 2018 Oct; 175(19):3832-3843. PubMed ID: 30051461
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia in translation: dissecting motivation in schizophrenia and rodents.
Simpson EH; Waltz JA; Kellendonk C; Balsam PD
Schizophr Bull; 2012 Nov; 38(6):1111-7. PubMed ID: 23015686
[TBL] [Abstract][Full Text] [Related]
7. CHL1 depletion affects dopamine receptor D2-dependent modulation of mouse behavior.
Fernandes L; Kleene R; Congiu L; Freitag S; Kneussel M; Loers G; Schachner M
Front Behav Neurosci; 2023; 17():1288509. PubMed ID: 38025382
[TBL] [Abstract][Full Text] [Related]
8. Changes of Locomotor Activity by Dopamine D2, D3 Agonist Quinpirole in Mice Using Home-cage Monitoring System.
Park J; Moon E; Lim HJ; Kim K; Hong YR; Lee JH
Clin Psychopharmacol Neurosci; 2023 Nov; 21(4):686-692. PubMed ID: 37859441
[TBL] [Abstract][Full Text] [Related]
9. ZFP804A mutant mice display sex-dependent schizophrenia-like behaviors.
Huang Y; Huang J; Zhou QX; Yang CX; Yang CP; Mei WY; Zhang L; Zhang Q; Hu L; Hu YQ; Song NN; Wu SX; Xu L; Ding YQ
Mol Psychiatry; 2021 Jun; 26(6):2514-2532. PubMed ID: 33303946
[TBL] [Abstract][Full Text] [Related]
10. Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats.
Brosda J; Becker T; Richter M; Jakobs M; Hörbelt T; Bendix I; Lückemann L; Schedlowski M; Hadamitzky M
Psychopharmacology (Berl); 2021 Apr; 238(4):1047-1057. PubMed ID: 33349900
[TBL] [Abstract][Full Text] [Related]
11. Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors.
Bhardwaj SK; Cui Q; Moquin L; Gratton A; Giros B; Srivastava LK
Neuropharmacology; 2021 Feb; 184():108440. PubMed ID: 33340529
[TBL] [Abstract][Full Text] [Related]
12. Multivariate genome-wide analysis of education, socioeconomic status and brain phenome.
Wendt FR; Pathak GA; Lencz T; Krystal JH; Gelernter J; Polimanti R
Nat Hum Behav; 2021 Apr; 5(4):482-496. PubMed ID: 33349686
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features.
Yang P; Knight WC; Li H; Guo Y; Perlmutter JS; Benzinger TLS; Morris JC; Xu J
Ann Clin Transl Neurol; 2021 Jan; 8(1):224-237. PubMed ID: 33348472
[TBL] [Abstract][Full Text] [Related]
14. Genetic Determinants of Gating Functions: Do We Get Closer to Understanding Schizophrenia Etiopathogenesis?
Rovný R; Besterciová D; Riečanský I
Front Psychiatry; 2020; 11():550225. PubMed ID: 33324248
[TBL] [Abstract][Full Text] [Related]
15. Effects of D
Péczely L; Kékesi G; Kállai V; Ollmann T; László K; Büki A; Lénárd L; Horváth G
Behav Brain Res; 2021 Feb; 400():113047. PubMed ID: 33279633
[TBL] [Abstract][Full Text] [Related]
16. The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion.
Peczely L; Ollmann T; Laszlo K; Lenard L; Grace AA
Int J Neuropsychopharmacol; 2022 Aug; 25(7):590-599. PubMed ID: 35348731
[TBL] [Abstract][Full Text] [Related]
17. Role of D2 dopamine receptors of the ventral pallidum in inhibitory avoidance learning.
Lénárd L; Ollmann T; László K; Kovács A; Gálosi R; Kállai V; Attila T; Kertes E; Zagoracz O; Karádi Z; Péczely L
Behav Brain Res; 2017 Mar; 321():99-105. PubMed ID: 28057528
[TBL] [Abstract][Full Text] [Related]
18. Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling.
Brown RW; Varnum CG; Wills LJ; Peeters LD; Gass JT
Pharmacol Biochem Behav; 2021 Dec; 211():173292. PubMed ID: 34710401
[TBL] [Abstract][Full Text] [Related]
19. The adenosine A(2A) receptor agonist CGS 21680 alleviates auditory sensorimotor gating deficits and increases in accumbal CREB in rats neonatally treated with quinpirole.
Brown RW; Bhide PG; Gill WD; Peeters LD
Psychopharmacology (Berl); 2020 Dec; 237(12):3519-3527. PubMed ID: 32772144
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
